MediPharm Labs Announces Voting Results From the 2023 Annual

TORONTO, June 29, 2023 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today announced

Related Keywords

Canada , United States , Toronto , Ontario , America , Miriam Mcdonald , David Pidduck , Michael Bumby , Shelley Potts , Chris Halyk , Chris Taves , Medipharm Lab , Company Board Of Directors , Health Canada , Medipharm Labs Corp , Pharm Labs , Medipharm Labs , Independent Directors , Chartered Professional Accountants , Good Manufacturing Practices , Pharmaceutical Drug Establishment License , North America , Good Manufacturing License ,